Modulation of inducible nitric oxide synthase induction by prostaglandin E2 in macrophages

Distinct susceptibility in murine J774 and RAW 264.7 macrophages

Wan Wan Lina, Bing Chang Chen, Ya Wen Hsu, Chii Ming Lee, Song Kun Shyue

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Prostaglandin E2 (PGE2) is the major cyclooxygenase metabolite in macrophages with complex proinflammatory and immunoregulatory properties. In the present study, we have compared the modulatory role of PGE2/cAMP- dependent signaling on induced nitric oxide (NO) production in two murine macrophages, J774 and RAW 264.7. With no effect on NO release by itself, PGE2 co-addition with lipopolysaccharide (LPS) resulted in a concentration- dependent enhancement in NO release and inducible NO synthase induction in J774, but not in RAW 264.7, macrophages. The potentiation effect of PGE2 in J774 cells was still seen when applied within 9 h after LPS treatment. Whereas RAW 264.7 macrophages release PGE2 with greater extent than J774 macrophages in response to LPS, indomethacin and NS-398, upon abolishing LPS- induced PGE2 release, caused a more obvious inhibition of NO release from J774 than RAW 264.7 cells. Thus, we suggest a higher positive modulatory role of PGE2 - either endogenous or exogenous - on NO formation in J774 cells. Supporting these findings, exogenous PGE2 triggers cAMP formation in J774 cells with higher potency and efficacy. Of interest, dBcAMP also elicits higher sensitivity in potentiating NO release in J774 cells. We conclude that the opposite effect of PGE2/cAMP signaling on macrophage NO induction depends on its signaling efficacy and might be associated with the difference in endogenous PGE2 levels.

Original languageEnglish
Pages (from-to)87-101
Number of pages15
JournalProstaglandins and Other Lipid Mediators
Volume58
Issue number2-4
DOIs
Publication statusPublished - Oct 1999
Externally publishedYes

Fingerprint

Macrophages
Nitric Oxide Synthase Type II
Dinoprostone
Modulation
Nitric Oxide
Lipopolysaccharides
Prostaglandin-Endoperoxide Synthases
Metabolites
Indomethacin

Keywords

  • cAMP
  • LPS
  • Murine macrophage
  • Nitric oxide
  • Prostaglandin E

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Modulation of inducible nitric oxide synthase induction by prostaglandin E2 in macrophages : Distinct susceptibility in murine J774 and RAW 264.7 macrophages. / Lina, Wan Wan; Chen, Bing Chang; Hsu, Ya Wen; Lee, Chii Ming; Shyue, Song Kun.

In: Prostaglandins and Other Lipid Mediators, Vol. 58, No. 2-4, 10.1999, p. 87-101.

Research output: Contribution to journalArticle

@article{549da9b123974a66b23957e07096da59,
title = "Modulation of inducible nitric oxide synthase induction by prostaglandin E2 in macrophages: Distinct susceptibility in murine J774 and RAW 264.7 macrophages",
abstract = "Prostaglandin E2 (PGE2) is the major cyclooxygenase metabolite in macrophages with complex proinflammatory and immunoregulatory properties. In the present study, we have compared the modulatory role of PGE2/cAMP- dependent signaling on induced nitric oxide (NO) production in two murine macrophages, J774 and RAW 264.7. With no effect on NO release by itself, PGE2 co-addition with lipopolysaccharide (LPS) resulted in a concentration- dependent enhancement in NO release and inducible NO synthase induction in J774, but not in RAW 264.7, macrophages. The potentiation effect of PGE2 in J774 cells was still seen when applied within 9 h after LPS treatment. Whereas RAW 264.7 macrophages release PGE2 with greater extent than J774 macrophages in response to LPS, indomethacin and NS-398, upon abolishing LPS- induced PGE2 release, caused a more obvious inhibition of NO release from J774 than RAW 264.7 cells. Thus, we suggest a higher positive modulatory role of PGE2 - either endogenous or exogenous - on NO formation in J774 cells. Supporting these findings, exogenous PGE2 triggers cAMP formation in J774 cells with higher potency and efficacy. Of interest, dBcAMP also elicits higher sensitivity in potentiating NO release in J774 cells. We conclude that the opposite effect of PGE2/cAMP signaling on macrophage NO induction depends on its signaling efficacy and might be associated with the difference in endogenous PGE2 levels.",
keywords = "cAMP, LPS, Murine macrophage, Nitric oxide, Prostaglandin E",
author = "Lina, {Wan Wan} and Chen, {Bing Chang} and Hsu, {Ya Wen} and Lee, {Chii Ming} and Shyue, {Song Kun}",
year = "1999",
month = "10",
doi = "10.1016/S0090-6980(99)00023-4",
language = "English",
volume = "58",
pages = "87--101",
journal = "Prostaglandins and Other Lipid Mediators",
issn = "0090-6980",
publisher = "Elsevier BV",
number = "2-4",

}

TY - JOUR

T1 - Modulation of inducible nitric oxide synthase induction by prostaglandin E2 in macrophages

T2 - Distinct susceptibility in murine J774 and RAW 264.7 macrophages

AU - Lina, Wan Wan

AU - Chen, Bing Chang

AU - Hsu, Ya Wen

AU - Lee, Chii Ming

AU - Shyue, Song Kun

PY - 1999/10

Y1 - 1999/10

N2 - Prostaglandin E2 (PGE2) is the major cyclooxygenase metabolite in macrophages with complex proinflammatory and immunoregulatory properties. In the present study, we have compared the modulatory role of PGE2/cAMP- dependent signaling on induced nitric oxide (NO) production in two murine macrophages, J774 and RAW 264.7. With no effect on NO release by itself, PGE2 co-addition with lipopolysaccharide (LPS) resulted in a concentration- dependent enhancement in NO release and inducible NO synthase induction in J774, but not in RAW 264.7, macrophages. The potentiation effect of PGE2 in J774 cells was still seen when applied within 9 h after LPS treatment. Whereas RAW 264.7 macrophages release PGE2 with greater extent than J774 macrophages in response to LPS, indomethacin and NS-398, upon abolishing LPS- induced PGE2 release, caused a more obvious inhibition of NO release from J774 than RAW 264.7 cells. Thus, we suggest a higher positive modulatory role of PGE2 - either endogenous or exogenous - on NO formation in J774 cells. Supporting these findings, exogenous PGE2 triggers cAMP formation in J774 cells with higher potency and efficacy. Of interest, dBcAMP also elicits higher sensitivity in potentiating NO release in J774 cells. We conclude that the opposite effect of PGE2/cAMP signaling on macrophage NO induction depends on its signaling efficacy and might be associated with the difference in endogenous PGE2 levels.

AB - Prostaglandin E2 (PGE2) is the major cyclooxygenase metabolite in macrophages with complex proinflammatory and immunoregulatory properties. In the present study, we have compared the modulatory role of PGE2/cAMP- dependent signaling on induced nitric oxide (NO) production in two murine macrophages, J774 and RAW 264.7. With no effect on NO release by itself, PGE2 co-addition with lipopolysaccharide (LPS) resulted in a concentration- dependent enhancement in NO release and inducible NO synthase induction in J774, but not in RAW 264.7, macrophages. The potentiation effect of PGE2 in J774 cells was still seen when applied within 9 h after LPS treatment. Whereas RAW 264.7 macrophages release PGE2 with greater extent than J774 macrophages in response to LPS, indomethacin and NS-398, upon abolishing LPS- induced PGE2 release, caused a more obvious inhibition of NO release from J774 than RAW 264.7 cells. Thus, we suggest a higher positive modulatory role of PGE2 - either endogenous or exogenous - on NO formation in J774 cells. Supporting these findings, exogenous PGE2 triggers cAMP formation in J774 cells with higher potency and efficacy. Of interest, dBcAMP also elicits higher sensitivity in potentiating NO release in J774 cells. We conclude that the opposite effect of PGE2/cAMP signaling on macrophage NO induction depends on its signaling efficacy and might be associated with the difference in endogenous PGE2 levels.

KW - cAMP

KW - LPS

KW - Murine macrophage

KW - Nitric oxide

KW - Prostaglandin E

UR - http://www.scopus.com/inward/record.url?scp=0345466464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345466464&partnerID=8YFLogxK

U2 - 10.1016/S0090-6980(99)00023-4

DO - 10.1016/S0090-6980(99)00023-4

M3 - Article

VL - 58

SP - 87

EP - 101

JO - Prostaglandins and Other Lipid Mediators

JF - Prostaglandins and Other Lipid Mediators

SN - 0090-6980

IS - 2-4

ER -